Phagocytes and humoral immunity to pneumonic plague

Advances in Experimental Medicine and Biology

Volumn 954, Issue , 2012, Pages 165-171

  Eisele, Nicholas A ^a,b   Brown, Charles R ^a,b   Anderson, Deborah M ^b  

^a University of Missouri   (United States)

^b UNIVERSITY OF MISSOURI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM ANTIBODY; CCR2 PROTEIN, MOUSE; CHEMOKINE RECEPTOR CCR2;

ANIMAL; ARTICLE; AUTOPHAGY; C3H MOUSE; C57BL MOUSE; HUMORAL IMMUNITY; IMMUNOLOGY; MOUSE; PHAGOCYTE; PHAGOCYTOSIS; PHYSIOLOGY; PLAGUE;

ANIMALS; ANTIBODIES, BACTERIAL; AUTOPHAGY; IMMUNITY, HUMORAL; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; PHAGOCYTES; PHAGOCYTOSIS; PLAGUE; RECEPTORS, CCR2;

EID: 84868160255     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4614-3561-7_21     Document Type: Conference Paper

References (42)

1. Agar SL, Sha J, Foltz SM et al (2008) Characterization of a mouse model of plague after aerosolization of Yersinia pestis CO92. Microbiology 154:1939-1948. doi: 154/7/1939 [pii] 10.1099/mic.0.2008/017335-0
2. Balamayooran G, Batra S, Balamayooran T et al (2011) Monocyte chemoattractant protein 1 regulates pulmonary host defense via neutrophil recruitment during Escherichia coli infection. Infect Immun 79:2567-2577. doi: IAI.00067-11 [pii] 10.1128/IAI.00067-11
3. Bashaw J, Norris S, Weeks S et al (2007) Development of in vitro correlate assays of immunity to infection with Yersinia pestis. Clin Vaccine Immunol 14:605-616. doi: CVI.00398-06 [pii] 10.1128/CVI.00398-06
4. Blaho VA, Zhang Y, Hughes-Hanks JM, Brown CR (2011) 5-Lipoxygenase-de fi cient mice infected with Borrelia burgdorferi develop persistent arthritis. J Immunol 186(5):3076-3084. doi: jimmunol.1003473 [pii] 10.4049/jimmunol.1003473
5. Cornelis GR (2006) The type III secretion injectisome. Nat Rev Microbiol 4:811-825. doi: nrmicro1526 [pii] 10.1038/nrmicro1526
6. Cowan C, Philipovskiy AV, Wulff-Strobel CR et al (2005) Anti-LcrV antibody inhibits delivery of Yops by Yersinia pestis KIM5 by directly promoting phagocytosis. Infect Immun 73:6127-6137. doi: 73/9/6127 [pii] 10.1128/IAI.73.9.6127-6137.2005
7. Cross M, Mangelsdorf I, Wedel A, Renkawitz R (1988) Mouse lysozyme M gene: isolation, characterization, and expression studies. Proc Natl Acad Sci U S A 85:6232-6236
8. Deshmane SL, Kremlev S, Amini S, Sawaya BE (2009) Monocyte chemoattractant protein-1 (MCP-1): an overview. J Interferon Cytokine Res 29:313-326. doi: 10.1089/jir.2008.0027
9. Eisele NA, Anderson DM (2009) Dual-function antibodies to Yersinia pestis LcrV required for pulmonary clearance of plague. Clin Vaccine Immunol 16:1720-1727. doi: CVI.00333-09 [pii] 10.1128/CVI.00333-09
10. Eisele NA, Lee-Lewis H, Besch-Williford C et al (2011) Chemokine receptor CXCR2 mediates bacterial clearance rather than neutrophil recruitment in a murine model of pneumonic plague. Am J Pathol 178:1190-1200. doi: S0002-9440(10)00204-X [pii] 10.1016/j. ajpath.2010.11.067
11. Faust N, Varas F, Kelly LM et al (2000) Insertion of enhanced green fl uorescent protein into the lysozyme gene creates mice with green fl uorescent granulocytes and macrophages. Blood 96:719-726
12. Goodyear A, Jones A, Troyer R et al (2010) Critical protective role for MCP-1 in pneumonic Burkholderia mallei infection. J Immunol 184:1445-1454. doi: jimmunol.0900411 [pii] 10.4049/jimmunol.0900411
13. Hara T, Nakamura K, Matsui M et al (2006) Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature 441:885-889. doi: nature04724 [pii] 10.1038/nature04724
14. Heath DG, Anderson GW Jr, Mauro JM et al (1998) Protection against experimental bubonic and pneumonic plague by a recombinant capsular F1-V antigen fusion protein vaccine. Vaccine 16:1131-1137. doi: S0264-410X(98)80110-2 [pii]
15. Hill J, Leary SE, Grif fi n KF et al (1997) Regions of Yersinia pestis V antigen that contribute to protection against plague identi fi ed by passive and active immunization. Infect Immun 65:4476-4482
16. Hill J, Copse C, Leary S et al (2003) Synergistic protection of mice against plague with monoclonal antibodies speci fi c for the F1 and V antigens of Yersinia pestis. Infect Immun 71:2234-2238
17. Hill J, Leary S, Smither S et al (2009) N255 is a key residue for recognition by a monoclonal antibody which protects against Yersinia pestis infection. Vaccine 27:7073-7079. doi: S0264-410X(09)01395-4 [pii] 10.1016/j.vaccine.2009.09.061
18. Kuma A, Hatano M, Matsui M et al (2004) The role of autophagy during the early neonatal starvation period. Nature 432:1032-1036. doi: nature03029 [pii] 10.1038/nature03029
19. Lathem WW, Crosby SD, Miller VL et al (2005) Progression of primary pneumonic plague: a mouse model of infection, pathology, and bacterial transcriptional activity. Proc Natl Acad Sci U S A 102:17786-17791. doi: 0506840102 [pii] 10.1073/pnas.0506840102
20. Mancuso P, Standiford TJ, Marshall T et al (1998) 5-Lipoxygenase reaction products modulate alveolar macrophage phagocytosis of Klebsiella pneumoniae. Infect Immun 66:5140-5146
21. Mancuso P, Nana-Sinkam P, Peters-Golden M (2001) Leukotriene B4 augments neutrophil phagocytosis of Klebsiella pneumoniae. Infect Immun 69:2011-2016. doi: 10.1128/IAI.69.4.2011-2016.2001
22. Nasser MW, Raghuwanshi SK, Grant DJ et al (2009) Differential activation and regulation of CXCR1 and CXCR2 by CXCL8 monomer and dimer. J Immunol 183:3425-3432. doi: jimmunol.0900305 [pii] 10.4049/jimmunol.0900305
23. Noel BL, Lilo S, Capurso D et al (2009) Yersinia pestis can bypass protective antibodies to LcrV and activation with gamma interferon to survive and induce apoptosis in murine macrophages. Clin Vaccine Immunol 16:1457-1466. doi: CVI.00172-09 [pii] 10.1128/CVI.00172-09
24. Parent MA, Wilhelm LB, Kummer LW et al (2006) Gamma interferon, tumor necrosis factor alpha, and nitric oxide synthase 2, key elements of cellular immunity, perform critical protective functions during humoral defense against lethal pulmonary Yersinia pestis infection. Infect Immun 74:3381-3386. doi: 74/6/3381 [pii] 10.1128/IAI.00185-06
25. Peters-Golden M (2008) Expanding roles for leukotrienes in airway in fl ammation. Curr Allergy Asthma Rep 8:367-373
26. Peters-Golden M, Brock TG (2003) 5-lipoxygenase and FLAP. Prostaglandins Leukot Essent Fatty Acids 69:99-109. doi: S095232780300070X [pii]
27. Pitt ML (2004) Nonhuman primates as a model for pneumonic plague. In: Public workshop on animal models and correlates of protection for plague vaccines, Gaithersburg, MD, 13 Oct 2004, pp. 222-248
28. Pujol C, Klein KA, Romanov GA et al (2009) Yersinia pestis can reside in autophagosomes and avoid xenophagy in murine macrophages by preventing vacuole acidi fi cation. Infect Immun 77:2251-2261. doi: IAI.00068-09 [pii] 10.1128/IAI.00068-09
29. Quenee LE, Cornelius CA, Ciletti NA et al (2008) Yersinia pestis caf1 variants and the limits of plague vaccine protection. Infect Immun 76:2025-2036. doi: IAI.00105-08 [pii] 10.1128/IAI.00105-08
30. Quenee LE, Berube BJ, Segal J et al (2010) Amino acid residues 196-225 of LcrV represent a plague protective epitope. Vaccine 28:1870-1876. doi: S0264-410X(09)01883-0 [pii] 10.1016/j.vaccine.2009.11.076
31. Quenee LE, Ciletti NA, Elli D et al (2011) Prevention of pneumonic plague in mice, rats, guinea pigs and nonhuman primates with clinical grade rV10, rV10-2 or F1-V vaccines. Vaccine. doi: S0264-410X(11)01022-X [pii] 10.1016/j.vaccine.2011.06.119
32. Rosenzweig JA, Jejelowo O, Sha J et al (2011) Progress on plague vaccine development. Appl Microbiol Biotechnol 91:265-286. doi: 10.1007/s00253-011-3380- 6
33. Szymczak WA, Deepe GS Jr (2009) The CCL7-CCL2-CCR2 axis regulates IL-4 production in lungs and fungal immunity. J Immunol 183:1964-1974. doi: jimmunol.0901316 [pii] 10.4049/jimmunol.0901316
34. Virgin HW, Levine B (2009) Autophagy genes in immunity. Nat Immunol 10:461-470. doi: ni.1726 [pii] 10.1038/ni.1726
35. Weeks S, Hill J, Friedlander A, Welkos S (2002) Anti-V antigen antibody protects macrophages from Yersinia pestis -induced cell death and promotes phagocytosis. Microb Pathog 32:227-237. doi: 10.1006/mpat.2002.0498 S0882401002904985 [pii]
36. Williamson ED, Eley SM, Grif fi n KF et al (1995) A new improved sub-unit vaccine for plague: the basis of protection. FEMS Immunol Med Microbiol 12:223-230
37. Williamson ED, Flick-Smith HC, Lebutt C et al (2005) Human immune response to a plague vaccine comprising recombinant F1 and V antigens. Infect Immun 73:3598-3608. doi: 73/6/3598 [pii] 10.1128/IAI.73.6.3598-3608.2005
38. Williamson ED, Flick-Smith HC, Waters E et al (2007) Immunogenicity of the rF1 + rV vaccine for plague with identi fi cation of potential immune correlates. Microb Pathog 42:11-21. doi: S0882-4010(06)00125-2 [pii] 10.1016/j.micpath.2006.09.003
39. Williamson ED, Packer PJ, Waters EL et al (2011) Recombinant (F1 + V) vaccine protects Cynomolgus macaques against pneumonic plague. Vaccine 29:4771-4777. doi: S0264-410X(11)00639-6 [pii] 10.1016/j.vaccine.2011.04.084
40. Zhang XW, Liu Q, Wang Y, Thorlacius H (2001) CXC chemokines, MIP-2 and KC, induce P-selectindependent neutrophil rolling and extravascular migration in vivo. Br J Pharmacol 133:413-421. doi: 10.1038/sj.bjp. 0704087
41. Zhao Z, Thackray LB, Miller BC et al (2007) Coronavirus replication does not require the autophagy gene ATG5. Autophagy 3:581-585. doi: 4782 [pii]
42. Zhao Z, Fux B, Goodwin M et al (2008) Autophagosomeindependent essential function for the autophagy protein Atg5 in cellular immunity to intracellular pathogens. Cell Host Microbe 4:458-469. doi: S1931-3128(08)00329-6 [pii] 10.1016/j.chom.2008.10.003